Discover

PALI
Palisade Bio, Inc.
1.16
2 x 1.16
1 x 1.18
bid
ask
-
0.03
2.52%
2 @ 04:00 PM
1.18 +0.02 (1.72%)
Ytd-50.64%
1y-40.21%
1.12
day range
1.20
1.10
52 week range
2.86
Open1.18Prev Close1.19Low1.12High1.20Mkt Cap202.15M
Vol3.09MAvg Vol2.73MEPS0.60P/E1.93Forward P/E-0.19
Beta1.33Short Ratio0.29Inst. Own3.58%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1550-d Avg1.67200-d Avg1.851yr Est30.33
Income Statement
Total Revenue500.00K
Revenues (USD)500.00K
Gross Profit500.00K
Operating Expenses12.20M
Research and Development Expense7.40M
Selling, General and Administrative Expense4.80M
Operating Income-11.70M
Net Income-10.57M
Net Income Common Stock-10.57M
Net Income Common Stock (USD)-10.57M
Consolidated Income-10.57M
Earnings per Basic Share-0.05
Earnings per Basic Share (USD)-0.05
Earnings per Diluted Share-0.05
Earning Before Interest & Taxes (EBIT)-10.57M
Earning Before Interest & Taxes (USD)-10.57M
Weighted Average Shares211.38M
Weighted Average Shares Diluted211.38M
Balance Sheet
Cash and Equivalents125.23M
Cash and Equivalents (USD)125.23M
Trade and Non-Trade Receivables500.00K
Current Assets127.26M
Total Assets127.32M
Current Liabilities5.25M
Total Liabilities5.57M
Accumulated Retained Earnings (Deficit)-172.90M
Shareholders Equity121.75M
Shareholders Equity (USD)121.75M
Assets Non-Current55.00K
Liabilities Non-Current321.00K
Trade and Non-Trade Payables1.84M
Cash Flow
Net Cash Flow from Financing147.00K
Net Cash Flow / Change in Cash & Cash Equivalents-7.46M
Issuance (Purchase) of Equity Shares147.00K
Net Cash Flow from Operations-7.60M
Share Based Compensation4.79M